Everforth, Inc. (EFOR)vsZepp Health Corp (ZEPP)
EFOR
Everforth, Inc.
$21.02
+1.35%
TECHNOLOGY · Cap: $871.66M
ZEPP
Zepp Health Corp
$18.01
+2.56%
TECHNOLOGY · Cap: $270.28M
Smart Verdict
WallStSmart Research — data-driven comparison
Everforth, Inc. generates 1437% more annual revenue ($3.98B vs $258.90M). EFOR leads profitability with a 2.5% profit margin vs -15.5%. EFOR earns a higher WallStSmart Score of 54/100 (C-).
EFOR
Buy54
out of 100
Grade: C-
ZEPP
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for EFOR.
Margin of Safety
+48.9%
Fair Value
$46.96
Current Price
$18.01
$28.95 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% revenue growth
Smaller company, higher risk/reward
ROE of 5.5% — below average capital efficiency
2.5% margin — thin
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EFOR
The strongest argument for EFOR centers on P/E Ratio, PEG Ratio. PEG of 0.64 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : EFOR
The primary concerns for EFOR are Revenue Growth, Market Cap, Return on Equity. Thin 2.5% margins leave little buffer for downturns.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
EFOR profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
EFOR generates stronger free cash flow (9M), providing more financial flexibility.
Bottom Line
EFOR scores higher overall (54/100 vs 38/100). ZEPP offers better value entry with a 48.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Everforth, Inc.
TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA
Efoora Inc. develops rapid diagnostic tests and biosensors for testing and diagnosing diseases including HIV, Hepatitis B and C, malaria, pregnancy, bovine spongiform encephalopathy (BSE), and chronic wasting disease (CWD). The company is headquartered in Buffalo Grove, Illinois.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other INFORMATION TECHNOLOGY SERVICES Stocks
Want to dig deeper into these stocks?